![]() |
|
|
Forward to a colleague |
||
Access Full Stories PerkinElmer post a 26 per cent rise in its Q4 profits, boosted by its laboratory and diagnostic equipment sales and confounding Wall Street expectations in the process... Read Thermo and FANUC unveil new robot for drug discovery Thermo Fisher Scientific aims to make automation in the drug discovery lab a whole lot easier through the development of an articulated robot specifically designed for pharmaceutical applications. ... Read WaferGen pushes PCR research with Malaysian subsidiary WaferGen has launched a new subsidiary in Kedah, Malaysia, with the express purpose of overseeing research and development of its real-time PCR system... Read Labcyte, Deerac Fluidics merge for improved liquid handling Labcyte and Deerac Fluidics, which both make liquid handling devices, albeit for different low-volume ranges, have decided to merge and combine their technologies... Read Laboratory Corp to buy drug discovery services firm Laboratory Corp has announced its intention to buy fellow US lab services firm Tandem Labs for an undisclosed sum... Read |
|||||||||||||||||
All News Headlines for: January | December | November |
|||||||||||||||||
|
Related Industry News Rhodium catalysts speed up drug synthesis A new series of rhodium-based catalysts are promising to turn chiral chemistry on its head, slashing the number of synthetic steps required to make chiral compounds, according to the scientist who discovered them... Read Pfizer reveals latest Exubera casualties 660 Pfizer employees are the latest casualties of the drug giant's failed bid to capture the diabetes market with its once-touted blockbuster, Exubera... Read ACS inks $130m IT contract with Allergan Affiliated Computer Services (ACS) is on the receiving end of Allergan's decision to outsource its IT functions, inking a $130m contract with the specialty pharma firm... Read Wyeth warns of job cut woes Wyeth is the latest big pharma firm to warn that major job cuts are on the cards, amidst a series of drug approval setbacks and generic erosion on profits... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||